Condition
Chronic Lung Diseases
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07597187Not Yet Recruiting
Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases
NCT04628039Completed
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs
NCT07075835Not ApplicableActive Not RecruitingPrimary
Enhanced External Counterpulsation for Patients With Ventilation Disorders
NCT00911794Not ApplicableCompletedPrimary
Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease
Showing all 4 trials